000 | 01183 a2200361 4500 | ||
---|---|---|---|
005 | 20250511215652.0 | ||
264 | 0 | _c19910502 | |
008 | 199105s 0 0 eng d | ||
022 | _a0024-3205 | ||
024 | 7 |
_a10.1016/0024-3205(91)90438-h _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKonicki, P E | |
245 | 0 | 0 |
_aThe acute effects of central- and peripheral-acting dopamine antagonists on plasma HVA in schizophrenic patients. _h[electronic resource] |
260 |
_bLife sciences _c1991 |
||
300 |
_a1411-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aDebrisoquin _xpharmacology |
650 | 0 | 4 |
_aDomperidone _xpharmacology |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluphenazine _xpharmacology |
650 | 0 | 4 |
_aHomovanillic Acid _xblood |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aReceptors, Dopamine _xdrug effects |
650 | 0 | 4 |
_aSchizophrenia _xblood |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aOwen, R R | |
700 | 1 | _aLitman, R E | |
700 | 1 | _aPickar, D | |
773 | 0 |
_tLife sciences _gvol. 48 _gno. 14 _gp. 1411-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0024-3205(91)90438-h _zAvailable from publisher's website |
999 |
_c2014338 _d2014338 |